Condition
Alexia
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Active Not Recruiting1
Completed1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06700005Recruiting
ReadMap: Reading in Stroke Alexia and Typical Aging
NCT04991519Active Not Recruiting
Brain-based Understanding of Individual Language Differences After Stroke
NCT04849091Unknown
Clinical Effectiveness of iReadMore for People With Alexia
NCT03662243Completed
Treatment for Reading and Writing Deficits Following Acquired Brain Injury
Showing all 4 trials